Eastman Chemical (EMN) is trading higher today as buy-side and retail flows key off renewed sell-side optimism, highlighted by recent price-target increases that keep the stock framed as a rebound/cost-action story into 2026. The most prominent recent change is a raised target to $84 from $78 alongside a reiterated Buy stance, which has helped reset expectations after the stock’s prior weakness.

Beyond ratings momentum, investors are also focusing on Eastman’s pricing actions in key product lines. The company has announced solvent price increases in North America and Latin America that took effect in March 2026 (or as contracts allow), a signal that management is pushing price to protect spreads and offset cost pressures where possible.

Attention now shifts to whether pricing and utilization improvements show up in near-term results and guidance commentary. Eastman’s most recent corporate update included first-quarter 2026 adjusted EPS expectations of $1.00 to $1.20 (excluding certain items and noting storm-related uncertainty), setting a near-term performance bar as the market looks for evidence that cost actions and seasonal volume/mix tailwinds are translating into earnings momentum ahead of the next report.